Palladino, Claudia
Ramis, Rebeca
Ezeonwumelu, Ifeanyi Jude
Biondi, Antonio
Carreras, Giulia
Fischer, Florian
Gallus, Silvano
Golinelli, Davide
Gorini, Giuseppe
Hassan, Shoaib
Kabir, Zubair
Koyanagi, Ai
Lazarus, Jeffrey V.
Mentis, Alexios-Fotios A.
Meretoja, Tuomo J.
Mokdad, Ali H.
Monasta, Lorenzo
Mulita, Francesk
Postma, Maarten J.
Tabarés-Seisdedos, Rafael
Thiyagarajan, Arulmani
Taveira, Nuno
Briz, Verónica
,
Article History
Received: 22 May 2023
Accepted: 21 May 2024
First Online: 20 June 2024
Declarations
:
: Not applicable.
: Not applicable.
: C Palladino reports contract funding support from Fundação para a Ciência e a Tecnologia (FCT), I.P. (national funding), under a contract-programme as defined by DL No. 57/2016 and Law No. 57/2017 (DL57/2016/CP1376/CT0004), (). I Ezenowumelu reports financial support for presenting at the 2023 Conference on Retroviruses and Opportunistic Infections (CROI 2023) by the CROI New Investigator Scholarship. V Lazarus reports grants or contracts from AbbVie, Gilead Sciences, MSD, Roche Diagnostics; royalties or licenses from Novavax; payment or honoraria for lectures from AbbVie, Gilead Sciences, Intercept, Janssen, Novo Nordisk; participation on a Data Safety Monitoring Board or Advisory Board with Same-visit hepatitis C testing and treatment to accelerate cure among people who inject drugs (The QuickStart Study): a cluster randomised control trial – Australia; leadership or fiduciary roles in board, society, committee or advocacy groups, paid or unpaid with EASL Public Health and Policy Committee as a member, HIV Outcomes as a co-chair, and SHARE Global Health Foundation; all outside the submitted work. A-F A Mentis reports grants or contracts from ‘MilkSafe: A novel pipeline to enrich formula milk using omics technologies’, a research co-financed by the European Regional Development Fund of the European Union and Greek national funds through the Operational Program Competitiveness, Entrepreneurship and Innovation, under the call RESEARCH—CREATE—INNOVATE (project code: T2EDK-02222), as well as from ELIDEK (Hellenic Foundation for Research and Innovation, MIMS-860); payment for expert testimony from saving as an external peer-reviewer for Fondazione Cariplo, Italy; leadership or fiduciary roles in board, society, committee or advocacy groups, paid or unpaid as an editorial board member for Systematic Reviews and Annals of Epidemiology, and as an associate editor for Translational Psychiatry; and other financial or non-financial interests having served as a scientific officer for “BGI Group” over the last year, all outside the submitted work. L Monasta reports support for the present manuscript from the Italian Ministry of Health (Ricerca Corrente 34/2017), payments made to the Institute for Maternal and Child Health IRCCS Burlo Garofolo. M J Postma reports stock or stock options in PAG BV (Groningen, Netherlands) and HealthEcore (Zeist, Netherlands). R Tabares-Sesdedos reports grants or contracts from the Spanish Ministry of Innovation, Institute of Health Carlos III (PID2021-129099OB-I00) and Generalitat Valenciana (CIPROM/2022/58), payments made to the University of Valencia, all outside the submitted work. V Briz reports financial support by Instituto de Salud Carlos III (PI18CIII/00020). All other authors declare no competing interests.